Development and pharmaceutical properties of a new oral dosage form of theophylline using sodium caseinate for the possible use in elderly patients

1995 ◽  
Vol 117 (1) ◽  
pp. 23-30 ◽  
Author(s):  
Atsushi Watanabe ◽  
Takehisa Hanawa ◽  
Masayasu Sugihara ◽  
Keiji Yamamoto
1995 ◽  
Vol 43 (5) ◽  
pp. 872-876 ◽  
Author(s):  
Takehisa HANAWA ◽  
Atsushi WATANABE ◽  
Takanori TSUCHIYA ◽  
Rieko IKOMA ◽  
Masato HIDAKA ◽  
...  

1995 ◽  
Vol 43 (2) ◽  
pp. 284-288 ◽  
Author(s):  
Takehisa HANAWA ◽  
Atsushi WATANABE ◽  
Takanori TSUCHIYA ◽  
Rieko IKOMA ◽  
Masato HIDAKA ◽  
...  

1996 ◽  
Vol 22 (5) ◽  
pp. 433-443 ◽  
Author(s):  
TAKEHISA HANAWA ◽  
ATSUSHI WATANABE ◽  
MASATO HIDAKA ◽  
MASAYASU SUGIHARA ◽  
MAKI WATANABE ◽  
...  

2000 ◽  
Vol 26 (10) ◽  
pp. 1091-1097 ◽  
Author(s):  
Takehisa Hanawa ◽  
Ryohko Maeda ◽  
Emi Muramatsu ◽  
Masahiko Suzuki ◽  
Masayasu Sugihara ◽  
...  

1978 ◽  
Vol 12 (12) ◽  
pp. 720-727
Author(s):  
T. Donald Rucker ◽  
Leonard Janis ◽  
Marialice Bennett

This pilot study describes and suggests quality of care considerations related to prescriptions ordered by podiatrists for ambulatory patients. During the four-month survey period, the average podiatrist initiated 120 prescription orders and utilized 26 different drug entities. The 44 practitioners employed 235 different preparations, headed by Lotrimin®, Mepergan Fortis® and erythromycin. Although refill orders were judged as conservative, questions are raised about the use of oral dosage form combination products, agents employed infrequently, and the desired therapeutic intention of some preparations.


Sign in / Sign up

Export Citation Format

Share Document